PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Tao Shen

East China University of Science and Technology

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · JOURNAL ARTICLE

Tumor-Targeting monodisperse hydroxyapatite core–shell nanospheres for overcoming multidrug resistance in cancer therapy via tumor-specific synergistic calcium overload

Journal of Nanobiotechnology

Single in vivo xenograft model with no comparator arm, surrogate endpoints (tumor growth, calcification), and no clinical data; represents early-stage proof-of-concept for a novel nanoparticle platform.

PreliminaryYuan Yuan Tao Shen Nanoparticle-based Drug Delivery

Reported

Nanosphere diameter47.0 ± 5.0 nm

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support